Page 4 - Biomedicine

Policy Initiatives —

Biomedical industry innovation

promotion program

In order to build Taiwan as a hub for the biomedical industry in the Asia-
Pacific region, our government launched the "Biomedical Industry Innovation
Program" in November 2016. Through strategies such as "building a complete
industrial ecosystem," "integrating innovative clusters," "making use of resources
on the international market," and "promoting characteristic and key industries," it is
hoped that by 2025, the output value of the medicinal product, medical device, and
health & wellness sectors in Taiwan will exceed US$30 billion, with 20 international
investigational new drugs developed and available on the market, 80 innovative
medical devices entering the international market, and at least ten health service-
related flagship brands successfully promoted, making the biotechnology industry
a new engine driving Taiwan's economic development. The following are options for
places in Taiwan where foreign companies might wish to locate or nd local companies
with which to collaborate:

1 National Biotechnology Park

To accommodate the development of translational medicine research,
the "Innovation Incubation Center" has been set up in the Nangang National
Biotechnology Park. Other institutions there include the National Laboratory Animal
Center (NLAC), the Development Center for Biotechnology (DCB), and the Taiwan Food
and Drug Administration. Therefore, the companies here have access to startups in
the biomedical eld to seek more collaborative opportunities. Besides, in the Park, the
resources are available to provide one-stop assistance with such matters as clinical
trials, commercialization of R&D results, and information on regulatory restrictions.

Operational Center of National Biotechnology Park
Contact
Information Telephone : 02-77505800#2446/2442 02-77505500#1452-1470
Address : 1F, Building C, National Biotechnology Park

02